Jane Street’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,348
| Closed | -$704K | – | 9442 |
|
|
2024
Q4 | $704K | Buy |
19,348
+14,088
| +268% | +$454K | ﹤0.01% | 6057 |
|
|
2024
Q3 | $158K | Buy |
+5,260
| New | +$159K | ﹤0.01% | 8789 |
|
|
2020
Q2 | – | Sell |
-5,807
| Closed | -$655K | – | 7055 |
|
|
2020
Q1 | $655K | Buy |
+5,807
| New | +$663K | ﹤0.01% | 3329 |
|
|
2019
Q1 | – | Sell |
-5,299
| Closed | -$979K | – | 5003 |
|
|
2018
Q4 | $979K | Buy |
5,299
+3,018
| +132% | +$486K | ﹤0.01% | 2591 |
|
|
2018
Q3 | $285K | Sell |
2,281
-72
| -3% | -$9.7K | ﹤0.01% | 4270 |
|
|
2018
Q2 | $366K | Buy |
2,353
+1,011
| +75% | +$168K | ﹤0.01% | 3926 |
|
|
2018
Q1 | $227K | Buy |
+1,342
| New | +$215K | ﹤0.01% | 4328 |
|
|
2017
Q2 | – | Sell |
-2,967
| Closed | -$660K | – | 4320 |
|
|
2017
Q1 | $660K | Buy |
2,967
+1,773
| +148% | +$418K | ﹤0.01% | 2561 |
|
|
2016
Q4 | $334K | Buy |
+1,194
| New | +$327K | ﹤0.01% | 3252 |
|
|
2016
Q3 | – | Sell |
-1,649
| Closed | -$438K | – | 3989 |
|
|
2016
Q2 | $549K | Buy |
1,649
+325
| +25% | +$103K | ﹤0.01% | 2670 |
|
|
2016
Q1 | $461K | Buy |
+1,324
| New | +$461K | ﹤0.01% | 2696 |
|
|
2015
Q4 | – | Sell |
-2,337
| Closed | -$601K | – | 3988 |
|
|
2015
Q3 | $721K | Buy |
+2,337
| New | +$551K | ﹤0.01% | 1920 |
|
|
2015
Q2 | – | Sell |
-3,167
| Closed | -$786K | – | 3619 |
|
|
2015
Q1 | $874K | Buy |
+3,167
| New | +$969K | 0.01% | 1486 |
|
|
2014
Q4 | – | Sell |
-1,608
| Closed | -$670K | – | 2477 |
|
|
2014
Q3 | $774K | Buy |
+1,608
| New | +$856K | 0.01% | 1094 |
|
|
2013
Q3 | – | Sell |
-141
| Closed | -$214K | – | 2713 |
|
|
2013
Q2 | $214K | Buy |
+141
| New | +$224K | ﹤0.01% | 2192 |
|
Other funds holding BIS
TRCT
Jane Street's BIS Position: Q1 2025 in Review
Jane Street sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q1 2025, closing a stake of 19,348 shares — an estimated $704K sold.
Jane Street first reported a position in BIS in Q2 2013 and held it in 15 quarters. The position peaked at $979K in Q4 2018. 4 funds tracked by Wall St. Rank hold BIS as of Q1 2025.
- Jane Street reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q1 2025 after selling out during the quarter.
- Jane Street sold 19,348 ProShares UltraShort NASDAQ Biotechnology shares in Q1 2025, an estimated $704K.
- Jane Street first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2013 and held it in 15 quarters.
- Jane Street's ProShares UltraShort NASDAQ Biotechnology position peaked at $979K in Q4 2018.
- 4 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q1 2025.
Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.